ESH Video


January 29, 2024


ESH-EBMT-EHA 3 rd Translational Research Conference


November 15-27, 2024

Paris, France



Chairs: Carmem Bonfim (Curitiba), Tim Brümmendorf (Aachen), Antonio Risitano (Naples), Sharon Savage (Bethesda)

Scientific Committee: Beatrice Drexler (Basel), Carlo Dufour (Genova), Morag Griffin (Leeds), Régis Peffault de Latour (Paris)
With the support of the Severe Aplastic Anaemia Working Party of the EBMT and the EHA SWG on Granulocyte and Bone Marrow Failures



The conference learning objectives

Upon completion of this CME activity, participants will:
• Improve understanding of the stem cell biology of BMF,
from genotoxic stress, inflammaging to failure
• Acquire knowledge of recent advances in Fanconi Anaemia,
Ribosome diseases and telomere biology disorder
• Gain insight into novel therapeutics of Paroxysmal Nocturnal Haemoglobinuria and idiopathic Aplastic Anaemia, including knowledge of complement cascade, the current developmental status of various targeted drugs and of novel antibody-based and small molecules based immunotherapeutic approaches, and their promise for future clinical application
• Acquire an overview of emerging approaches and new challenges such as genetic editing of haemopoietic stem cells, single cell RNA sequencing in haemopoiesis and genetic predisposition for myeloid malignancies.




On behalf of the European School of Haematology, the Severe Aplastic Anaemia Working Party of the EBMT and the EHA SWG on Granulocyte and Bone Marrow Failures, we are pleased to announce and to invite you to the 3rd ESH-EBMT-EHA Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes.

About the Conference:

The ESH-EBMT-EHA 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and paediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies.

In good tradition of ESH, we will put special effort on low threshold exchange between young scientists and experts in the field, as well as between clinicians and basic scientists. Meet-the-experts workshop as well as poster walks will allow to highlight topics of special attention and to enable further in-depth exchange. Our dedicated faculty will secure the highest standard of both clinical, translational and basic research.




for Brief Oral Communications or Poster Presentations
Deadline: August 25th, 2024




To read the preliminary programme, click here!

For more information, click here!